0001554289-16-000002.txt : 20161028
0001554289-16-000002.hdr.sgml : 20161028
20161027204448
ACCESSION NUMBER: 0001554289-16-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20161028
DATE AS OF CHANGE: 20161027
EFFECTIVENESS DATE: 20161028
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: CURE PHARMACEUTICAL Corp
CENTRAL INDEX KEY: 0001554289
IRS NUMBER: 452717791
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-273395
FILM NUMBER: 161956764
BUSINESS ADDRESS:
STREET 1: 1620 BEACON PLACE
CITY: OXNARD
STATE: CA
ZIP: 93033
BUSINESS PHONE: 805 824 0410
MAIL ADDRESS:
STREET 1: 1620 BEACON PLACE
CITY: OXNARD
STATE: CA
ZIP: 93033
D
1
primary_doc.xml
X0707
D
LIVE
0001554289
CURE PHARMACEUTICAL Corp
1620 BEACON PLACE
OXNARD
CA
CALIFORNIA
93033
805 824 0410
CALIFORNIA
None
None
Corporation
true
Rob
Davidson
1620 Beacon Place
Oxnard
CA
CALIFORNIA
93033
Executive Officer
Director
Chief Executive Officer
Ed
Maliski
1620 Beacon Place
Oxnard
CA
CALIFORNIA
93033
Director
Vic
Branstetter
1620 Beacon Place
Oxnard
CA
CALIFORNIA
93033
Director
Wayne
Nasby
1620 Beacon Place
Oxnard
CA
CALIFORNIA
93033
Director
Ian
Sephton
1620 Beacon Place
Oxnard
CA
CALIFORNIA
93033
Director
Mark
Udell
1620 Beacon Place
Oxnard
CA
CALIFORNIA
93033
Executive Officer
Chief Financial Officer
Pharmaceuticals
Decline to Disclose
- 06b
false
2011-07-25
false
true
true
true
Convertible Promissory Note and Option to Purchase Common Stock
false
0
1500000
1500000
0
false
1
0
0
0
false
CURE PHARMACEUTICAL Corp
/s/ Mark Udell
Mark Udell
Chief Financial Officer
2016-10-27